# Heparin vs Placebo for Cardiac Catheterization

> **NCT04374799** · PHASE3 · RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 1623 (estimated)

## Conditions studied

- Cardiac Disease

## Interventions

- **DRUG:** Heparin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04374799
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-05
- **Primary completion:** 2026-08
- **Final completion:** 2026-12
- **Target enrollment:** 1623 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04374799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04374799, "Heparin vs Placebo for Cardiac Catheterization". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04374799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*